Nation's Second Participant Enrolls In Human Embryonic Stem Cell Trial

Nation's Second Participant Enrolls In Human Embryonic Stem Cell Trial: Researchers at Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine and The Rehabilitation Institute of Chicago recently enrolled their first subject in a national clinical research trial of a human embryonic stem cell-based therapy for participants with a subacute thoracic spinal cord injury. This is only the second enrollment nationwide in the study sponsored by Geron Corp. Northwestern is one of five sites currently open for subject enrollment. The trial will enroll up to 10 subjects nationally.